POLYBODIES Trademark

Trademark Overview

On Wednesday, February 21, 2024, a trademark application was filed for POLYBODIES with the United States Patent and Trademark Office. The USPTO has given the POLYBODIES trademark a serial number of 79394107. The federal status of this trademark filing is FINAL REFUSAL - MAILED as of Sunday, February 9, 2025. This trademark is owned by National Institute Of Pharmaceutical Education And Research Niper. The POLYBODIES trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparation for use in the treatment of inflammation and inflammatory disorders
polybodies

General Information

Serial Number79394107
Word MarkPOLYBODIES
Filing DateWednesday, February 21, 2024
Status645 - FINAL REFUSAL - MAILED
Status DateSunday, February 9, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing5 - Drawing with word(s) / letter(s) / number(s) in Stylized form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Goods and ServicesPharmaceutical preparation for use in the treatment of inflammation and inflammatory disorders

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, April 25, 2024
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameNational Institute Of Pharmaceutical Education And Research Niper
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressIN

Trademark Events

Event DateEvent Description
Thursday, April 25, 2024SN ASSIGNED FOR SECT 66A APPL FROM IB
Monday, May 6, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, September 13, 2024NON-FINAL ACTION WRITTEN
Monday, May 6, 2024APPLICATION FILING RECEIPT MAILED
Wednesday, September 11, 2024ASSIGNED TO EXAMINER
Monday, September 16, 2024REFUSAL PROCESSED BY MPU
Saturday, September 14, 2024NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Monday, September 16, 2024NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Monday, October 7, 2024REFUSAL PROCESSED BY IB
Tuesday, January 7, 2025ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, January 7, 2025APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, January 7, 2025TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, January 7, 2025TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, January 7, 2025TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, January 13, 2025TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, January 13, 2025CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, January 13, 2025TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sunday, February 9, 2025FINAL REFUSAL E-MAILED
Sunday, February 9, 2025FINAL REFUSAL WRITTEN
Sunday, February 9, 2025NOTIFICATION OF FINAL REFUSAL EMAILED

Related Keywords

polybodies inflammatory disorders inflammation treatment preparation pharmaceutical